ZOOM Study N=364 TORO 1 and 2 Pooled analysis [4, 8] N=661   Observed data (patients with viral load available) Observed data for patients on enfuvirtide treatment Sensitivity analysis on total population Missing = Failure Intent-to-treat On treatment HIV RNA < 400 copies/mL           6 months 63% 64% 47% 37% NA 12 months 61% 61% 41% 30% 34% 24 months 74% 77% 43% 27% 48% HIV RNA < 50 copies/mL           6 months 41% 42% 31% 23% NA 12 months 39% 40% 26% 18% 23% 24 months 56% 57% 32% 18% 32% NA: not available

Table 2: Description of virologic outcome in ZOOM and TORO studies.

Goto home»